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ABSTRACT   
 
BACKGROUND: Laboratory services have been described as the 
major processes contributing to safe patient care in the modern 
healthcare sector. However, occurrences of errors in the overall 
testing processes impair the clinical decision-making process. 
Such errors are supposed to be high in resource-poor countries, 
like Ethiopia. The objective of this study was to assess errors in the 
total testing process in the Clinical Chemistry laboratory of the 
University of Gondar Hospital, Northwest Ethiopia 
METHODS: A cross-sectional study was conducted at the 
University of Gondar Hospital from February to March 2016. All 
the required data were collected using established quality 
indicators. Data were analyzed using SPSS version 20. 
Frequencies and cross-tabulations were used to summarize 
descriptive statistics. 
RESULTS: A total of 3259 samples and corresponding laboratory 
request forms were received for analysis. The analysis of the 
overall distribution of errors revealed that 89.6% were pre-
analytical errors, 2.6% were analytical, and 7.7% were post-
analytical errors. Of the pre-analytical errors, incomplete request 
form filling was the most frequent error observed, followed by 
sample rejection rate (3.8%). Analytical errors related to internal 
and external quality control exceeding the target range, (14.4%) 
and (51.4%) respectively, were reported. Excessive turnaround 
time and unreported critical value cases were the major defects in 
the post-analytical phase of quality assurance. 
CONCLUSION: The present finding showed relatively high 
frequency of errors, which alarms the importance of quality 
indicators to assess errors in the total testing process. The 
University of Gondar Hospital laboratory should improve the 
quality of healthcare services based on these findings using 
laboratory standards. 
KEYWORDS: Analytical errors; clinical laboratory; post-
analytical errors; pre-analytical errors; quality  
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Laboratory services are the backbone of the 
modern healthcare sector (1). Diagnostic test 
results provide information that can be used to aid 
the patient, the physician and others in reaching 
decisions (2). The impact of laboratory testing in 
patient care contributes to greater than 60% of 
medical decisions (3). However, the analysis 
performed in the laboratory is subjected to 
variance; hence, every clinical laboratory must 
have adequate procedures to assure the quality of 
the medical results reported. The quality of tests 
performed in laboratory medicine must allow 
clinicians to practice good medicine (4-6). 
Quality in laboratory medicine is the 
guarantee that each and every step in the total 
testing process (TTP) is correctly performed, thus 
ensuring valuable decision making and effective 
patient care (6). Errors can occur in any step of 
the process. These in turn directly lead to 
increased healthcare costs and decreased patient 
satisfaction. The impact of error during laboratory 
testing process can affect patient care in many 
ways, such as delay in reporting, unnecessary 
redraws, misdiagnosis, and improper treatment 
(7).  
Evidence in recent decades proves that pre-, 
intra- and post-analytical processes are equally 
important for ensuring quality laboratory service. 
Thus, quality in clinical laboratories should be 
assured by focusing on all analytical aspects. 
Studies showed that the pre-analytical phase 
accounts for 46% to 68.2% of the errors observed 
during the TTP compared to 13-32% in the 
analytical and 19-47% in the post-analytical 
phases. Pre-analytical and post-analytical errors 
combined account for 93% of the total errors 
encountered in the laboratory (8-10). 
Evidence showed that the risk of 
inappropriate care due to laboratory errors ranges 
from 6.4% to 12% and the incidence of further 
inappropriate investigations is much higher (19%) 
(11, 12). Poor laboratory performance that causes 
an error and delays in diagnosis, and treatment is 
an obstacle to optimal patient care, particularly in 
high volume patient care areas such as the 
University of Gondar (UOG) Hospital. Although 
a study was conducted in UOG Hospital 
laboratory focused on pre-analytical errors only, it 
did not show errors occurring during the TTP. In 
addition, UOG Hospital laboratory was 
recognized as a three-star level laboratory in the 
World Health Organization Regional Office for 
Africa accreditation system on November 18, 
2011, but its level has come down to one-star 
level on September 1, 2015 (13). That is a big 
issue which questions laboratory performance.  
Identifying and evaluating errors in TTP is 
mandatory by using a quality indicator (14). The 
hypothesis of this study was an inspection of the 
TTP using quality indicator would enable 
identification of critical errors at any point of 
laboratory procedure. In addition, persistent 
evidence-based identification of laboratory 
performance through evaluation of pre-, intra-, 
and post-analytical errors that undermine 
laboratory quality status helps to put a new 
strategy to minimize and control errors, and 
improve processes. Therefore, the aim of this 
study was to assess errors in TTP in the Clinical 
Chemistry laboratory of UOG Hospital. 
 
METHODS AND MATERIALS  
 
Study area: The study was conducted at UOG 
Hospital laboratory. Gondar Town is located 738 
km far from Addis Ababa, the capital city of 
Ethiopia. The town has around nine government 
health centers and one University Hospital. The 
Hospital is a tertiary level teaching Hospital that 
provides health services for more than 5 million 
inhabitants in Northwest Ethiopia. UOG Hospital 
has diagnostic laboratory service like Clinical 
Chemistry, Hematology, Microbiology, 
Parasitology, Serology, Urinalysis and Emergency 
laboratories that plays important role in teaching, 
research and community service. The laboratory 
is equipped with automated instruments in the 
Clinical Chemistry section, such as Mindray - BS 
120 Auto Chemistry Analyzer, mini 
VIDAS®automated immunoassay, and Roche 
Diagnostics AVL 9180 Series Electrolyte 
Analyzers. Previously, there was laboratory 
information system (LIS). However, the LIS 
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service currently is non-functional during the 
study period. Clinical Chemistry performs a large 
number of tests. These include lipid profile tests, 
kidney function tests, liver function tests, 
electrolyte profile tests, hormonal analysis, cancer 
markers detection, measurement of glucose and 
troponin. Approximately on average, 120 samples 
are run per day. These tests are manipulated in 
Clinical Chemistry with four medical laboratory 
scientists and two clinical chemists. 
Study design and period: A cross-sectional 
study was conducted from February 1 to March 
30,2016, to assess errors in TTP in the Clinical 
Chemistry laboratory of UOG Hospital. 
Sample size and sampling technique: The study 
included all test requests that were referred for 
Clinical Chemistry tests at the UOG Hospital 
during the study period. The total sample size of 
the study was the total number of requests ordered 
for Clinical Chemistry tests during the study 
period. All test requests ordered for Clinical 
Chemistry tests taking into account venous blood 
sample were included using consecutive sampling 
technique.  
Data collection methods and processes: Process 
inspection sheets were formulated to help in the 
evaluation of pre-, intra- and post-analytical errors 
for Clinical Chemistry tests at UOG Hospital. 
Inspection sheets were based upon the 
International Federation of Clinical Chemistry 
(IFCC) approved quality indicators (14) and 
literature review of similar studies (9, 15-18) 
(Table 1). Nine investigators participated in this 
study. Training was given for all investigators. 
Data were collected in the Clinical Chemistry 
section during routine hours each day in the study 
period. The principal investigator has closely 
followed and checked the data collection process 
to ensure the completeness and consistency of the 
collected data. 
Inclusion and exclusion criteria: The study was 
conducted on processes at pre-, intra- and post-
analytical phases. Requests which were ordered 
for Clinical Chemistry tests taking into account 
venous blood sample (serum sample) were 
included in the study. 
Urine and other body fluids such as serous 
fluid, synovial fluid and cerebrospinal fluid were 
not included in this study. Moreover, test requests 
ordered for Clinical Chemistry tests only were 
included. Those requested analyses for 
Hematology, Coagulation, Serology, Urinalysis, 
Emergency laboratory and Microbiology were not 
included in this study. 
Data management and quality control: Pre-test 
of the checklist was done to check clarity, 
acceptability, and consistency of the structured 
inspection sheets. The necessary correction was 
taken before the actual data collected. The data 
collection, in accordance with quality indicators, 
was checked by a senior laboratory technologist 
and the principal investigator. Close follow-up 
was done by the principal investigator. The filled 
checklist was collected after consistency and 
completeness were checked.  
Data analysis and interpretation: The data were 
checked for completeness and entered to EPI info 
version 3.5.3 and transferred to Statistical 
Package for the Social Sciences (SPSS) version 
20 (IBM Corporation, New York, United States) 
for analysis. Frequencies, and cross tabulations 
were used to summarize descriptive statistics. The 
data were compared using independent t-test.  
 
Ethical clearance: Ethical clearance was taken 
from the Research and Ethical Review Committee 
of School of Biomedical and Laboratory Sciences, 
UOG. Permission letter was secured from both the 
medical director of the hospital and the diagnostic 
coordinator of UOG hospital. All the collected 
data were kept confidential by using codes instead 
of any personal identifiers. Detectable errors were 
linked to the responsible personnel for better 





According to this study, 3259 blood samples and 
their request papers were inspected. Of these, 
2287(70.1%) were from the Outpatient 
Department (OPD) and 972(29.8%) were from the 
Inpatient Department (IPD). 
Parameters on the test request form: The 
information provided on each request form was 
examined. Only 3(0.09 %) requisition papers were 
found to have complete data (a requested paper 
containing all the necessary information); the rest 
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did not contain full information that they were 
supposed to contain. Indicators of patient 
information such as clinical data 3226(99%) were 
not filled on the test request form. However, 
patient’s name, sex, age and hospital number were 
relatively more mentioned. The name, 
1262(38.7%), and the exact address, 60(1.8%), of 
the requesting physicians were not specified on 
the test request form. Sample quality indicators on 
test request form, time of collection (99.3%) and 
date of sampling (40.1%) were missed on test 
request form (Table 2). 
 
Table 1: Quality indicators in the pre-analytical, analytical and post-analytical phases 
 
Quality indicators of pre-analytical phase 
Number of requests with errors concerning patient name/total number of requests   
Number of requests with errors concerning hospital number/total number of requests   
Number of requests with errors concerning patient sex/total number of requests  
Number of requests with errors concerning patient age/total number of requests 
Number of requests with errors concerning physician name/total number of requests   
Number of requests with errors concerning patient clinical data/total number of requests 
Number of requests with errors concerning patient location/total number of requests 
Number of requests with errors concerning date of sampling/total number of requests   
Number of requests with errors concerning test ordered/total number of requests   
Number of requests with errors concerning time of sampling/total number of requests 
Number of samples haemolysed/total number of samples 
Number of samples lipemic /total number of samples 
Number of insufficient volume of samples/ total number of samples 
Number of samples mislabeled /total number of samples 
Number of samples with no request/total number of samples 
Quality indicators of analytical phase  
Number of IQC values that exceed the selected target /total quality control run 
Number of EQC exceeding the target range in EQAS-PT schemes / total number of quality control runin EQA 
schemes 
Quality indicators of post-analytical phase  
Number of reports delivered outside the specified time/total number of reports  
Number of critical values not communicated/total number of reports 
Number of data transcription errors/total number of reports 
	
EQAS: External Quality Assessment schemes,EQC: external quality control , IQC: Internal Quality Control, IPD: Inpatient 
Department, OPD: Out Patient Department, PT: Proficiency Testing, UOG: University of Gondar 
	
Table 2: Frequency of missed data on routinely submitted test request forms in Clinical Chemistry laboratory at UOG 
Hospital from February to March 2016, Northwest Ethiopia 
 
Data type  OPD N(%) n=2287 IPD N(%) n=972 Total N(%) n=3259 Sig. (2-tailed) 
Patient name  0(0.0) 0(0.0) 0(0.0)  
Hospital number 1(0.04) 3(0.3) 4(0.1) 0.048 
Patient sex  13(0.6) 5(0.5) 18(0.6) 0.849 
Patient age  14(0.6) 5(0.5) 19(0.6) 0.737 
Physician name  1006(44.0) 256(26.3) 1262(38.7) 0.000 
Patient clinical data  2269(99.2) 957(98.5) 3226(99.0) 0.049 
Patient location 32(1.4) 28(2.9) 60(1.8) 0.000 
Date of sampling  1072(46.9) 235(24.2) 1307(40.1) 0.000 
Test ordered  1(0.04) 0(0.0) 1(0.03) 0.515 
Time of sampling  2281(99.7) 956(98.4) 3237(99.3) 0.000 
Over all incomplete  request form 2286(99.9) 970(99.8) 3256(99.9) 0.160 
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Sample quality indicators: The other 
observation made during the study period was an 
assessment of sample quality. Of the total number 
of 3259 samples submitted to the laboratory for 
Clinical Chemistry tests, 123(3.8%) were rejected. 
The most common reason for sample rejection 
was haemolysis, 41(1.3%), followed by the 
request with no sample or sample with no request, 
39(1.2%), and mislabeled, 35(1.1%) (Table 3). 
 
Quality indicators covering the analytical 
phase: Unacceptable performances in external 
quality control (EQC) accounted for 18(51.4%), 
followed by non-conformity of internal quality 
control (IQC) 81(14.4%) (Table 4).  
 
Table 3: Type and frequency of reason for sample rejected in Clinical Chemistry laboratory at UOG 
Hospital from February to March 2016, Northwest Ethiopia. 
 
 






Haemolysis 19(0.6) 22(0.7) 41(1.3) 
Lipemic sample  4(0.1) 0(0.0) 4(0.1) 
Insufficient volume of sample 0(0.0) 2(0.1) 2(0.1) 
Mislabeled 29(0.9) 6(0.2) 35(1.1) 
Sample with no request/request with no 
sample 
28(0.9) 11(0.3) 39(1.2) 
Test not ordered/inappropriate test 0(0.0) 2(0.1) 2(0.1) 
Total  80(2.5 ) 43(1.3) 123(3.8) 
	
IPD: Inpatient Department, OPD: Out Patient Department, UOG: University of Gondar 
 
Table 4: Error frequency of analytical phase in Clinical Chemistry laboratory at UOG Hospital from 
February to March 2016, Northwest Ethiopia. 
 
 IQC N (%)  EQC N (%) Total N (%) 
Pass 481(85.6) 17(48.6) 498(83.4) 
Fail 81(14.4) 18(51.4) 99(16.6) 
Total 562(100.0) 35(100.0) 597(100.0) 
IQC: Internal Quality Control, EQC: External Quality Control 
 
Quality indicators in the post-analytical phase: 
In the post-analytical phase, 291(9.3%) errors 
were observed. Excessive turnaround time (TAT), 
270(8.6%), contributed to the majority of post-
analytical errors followed by unreported critical 
value cases, 15(0.48). All critical value cases were  
not communicated to the concerned physician. 
Although this laboratory does not have functional 
laboratory information system (LIS) currently, 
manual reporting accounted for only 6(0.2%) 
transcription errors (Table 5).  
Pre-analytical phase was found to be error prone 
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Table 5: Error frequency of post-analytical phase in Clinical Chemistry laboratory at UOG Hospital from 
February to March 2016, Northwest Ethiopia. 
 
 
TAT: turnaround time, UOG: University of Gondar 
  
Table 6: Distribution of total testing process error frequency in the Clinical Chemistry laboratory at UOG 
Hospital from February to March 2016, Northwest Ethiopia. 
 
 
Phase  Error frequency (%) Error frequency (%) 
 A B 
Pre‑analytical*6518 3379(51.8) 3379(89.6) 
Analytical*597 99(16.6) 99(2.6) 
Post‑analytical*3136 291(9.3) 291(7.7) 
Total*10251 3769(36.8) 3769(100) 
 
The asterisk (*) indicates denominator for each phase in the ‘A’ column, A: Error frequency in the pre-analytical, 




In this study, errors in TTP in Clinical Chemistry 
laboratory was assessed based on IFCC quality 
indicators. Currently, there is considerable 
emphasis on managing TTP in clinical 
laboratories. This supports a quantitative basis for 
interested parties aiming to guarantee 
improvement and up-to-date performance in care 
and processes (14, 19). 
Accordingly, 3259 request papers submitted 
to the Clinical Chemistry laboratory, pre-
analytical errors associated with request form 
accounted for 49.9% due to the omission of 
important data. Significantly, 3256(99.9%) 
request papers were incomplete lacking one or 
more of the required information. The only well-
documented parameter appeared on all request 
forms in this study was the patient’s name. This 
result was in line with findings from Ethiopia 
(18), Pakistan (20) and Ghana (21). This was not 
astonishing since it was very likely that the 
request would have been rejected if the patient’s 
name was not mentioned. However, the name of 
the attending physician was omitted in 38.7% of 
test request forms observed. This figure was 
higher than a study conducted in Nigeria which 
reported 19.8% (22). The rationale behind this 
figure could be attributed to lack of awareness and 
variability of physicians attending the patient on 
one site since most physicians visiting the patient 
were interns. 
Besides, this study showed that clinical data 
(99%) and time of sampling (99.3%) were found 
to be incomplete on the request forms. This result 
was consistent with a previous study done in a 
similar setting in Ethiopia (18) in which the 
authors stated that clinical data (97.8%) and time 
of sampling (100%) had been missed. This result 
indicated no improvement after the previous 
report at similar setting in Ethiopia (18) which 
demands extra management effort to create 
awareness concerning the impact of incomplete 
test request form on the quality of patient care.  
Parameter  (n = 3136) 
Frequency (%) 
Excessive TAT                   270 (8.6) 
Not informed critical result                   15 (0.48) 
Data transcription errors                   6 (0.2) 
Total                    291 (9.3) 
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Moreover, 40.1% of the request forms 
observed did not state the date of sampling. This 
was comparable to results obtained in a similar 
study conducted in Ghana (37.3%) (21), but, 
higher than results obtained in Nigeria (0.5%) 
(23). This variation could be attributed to the 
workload on physicians, attitudinal difference and 
negligence among physicians, lack of monitoring 
by the concerned body or improper orientation 
about the impact of incomplete test request form 
on the quality of patient care.  
In our study, 3.8% samples were rejected for 
various reasons. This figure was lower than a 
study conducted in India (4.91%) (19), but higher 
than the rejection rate reported in Ethiopia (2.4%) 
(18), (1.4%) (24), Turkey (0.91%) (25) and USA 
(0.74%) (26). High staff turnover, the periodic 
influx of students, frequent job rotation of 
phlebotomists, increased patient flow or poor 
quality management system, would be the main 
cause of increased sample rejection. 
In this study, the most common frequent cause of 
sample rejection was haemolysis (33.3%) which 
is comparable in a study conducted in Ethiopia 
(24), Nigeria (27) and Spain (28) which reported 
haemolysis as the main cause of sample rejection. 
Increased haemolysis observed from this study 
could be as a result of poor phlebotomy 
procedures or periodic influx of students in the 
institutions.  
Remarkably, the second frequent reason for 
sample rejection was a sample with no 
request/request with no sample accounted for 
31.7%, which is higher than the result reported in 
Ethiopia (24). The same figure for mislabeled 
samples was 28.5% in the current study. This 
could be due to excessive patient load 
(disproportionate of patients to phlebotomists), 
the absence of functional LIS and pneumatic tube 
complicated proper labeling and delivery of 
samples with corresponding request forms. Loss 
of attention and poor communication between 
staffs might further aggravate the problem. 
In our study, a total of 16.6% analytical 
errors were seen as compared to an Indian report 
(5.07%) (19). Of these, unacceptable performance 
in IQC accounted for 14.4%, which could be due 
to the improper reconstitution of quality control 
(QC) material, inappropriate storage, instability of 
reagents or contamination or calibration drift. 
This figure (14.4%) was much higher than an 
Indian report (0.6%) of non-conformity of QC 
(29). The difference could be attributed to the 
difference in the use of QC material, operator, 
type of machine, environmental condition, or 
implementation of quality assurance system. 
Unsatisfactory evidence has been found from 
the external agency as part of the involvement of 
proficiency testing program which showed EQC 
exceeding the target range accounted for 51.4%, 
indicated a need to address shortcomings related 
to analytical process, which is much higher as 
compared to a report of Spain (0.8%) (30). 
Instability of the instrument due to fluctuation in 
electricity, lack of laboratory staff training about 
automation and quality management system, staff 
turnover or frequent changes of staffs without 
training could be attributed to the remarkable 
increment in the analytical errors. 
In the current study, the frequency of errors 
in post-analytical phase was 9.3%, almost triple 
than the study conducted in India (3.2%) (29). 
Even though, the percentage of transcription error 
contributes much in some literature (29), in this 
study, excessive TAT (8.6%) contributed to the 
majority of post-analytical errors. Electrical 
fluctuation, shortage of distilled water and 
workload could be the cause of not reporting 
results within a specified time. Manual reporting 
of results accounted only 0.2% transcription 
errors. Since it is all about the life of the human 
being, it does not mean that the result of this study 
is low. 
Another important aspect of the post-
analytical phase of the testing process was critical 
value reporting. On examination of critical value 
reporting, 15(0.48%) critical value cases were 
observed almost double in the Indian report 
(0.21%) (19), and none of them has been 
communicated to the concerned physician. Lack 
of functional LIS, poor awareness among 
laboratory staffs, missed parameter on the test 
request form such as patient address, attending 
physicians and telephone complicated in difficulty 
to notify within the target time. Failure to deliver 
a critical value notification within the indicated 
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time could be life-threatening if the patient is left 
untreated. In fact, implementation of electronic 
LIS can improve the post-analytical phase. This 
might eliminate transcriptional errors and delay in 
results. 
In general, the overall statistics showed that 
the error frequency was 89.6% in the pre-
analytical phase, 2.6% in the analytical and 7.7% 
in the post-analytical phase. Results reported in 
the Netherlands with a certain difference to this 
study showed that the distribution of errors; pre-
analytical 68.2%, analytical 13.3% and post-
analytical 18.5% (31). This variation is difficult to 
explain with regard to the relative frequency of 
errors observed in the different phases, being 
different in work complexity, in the 
implementation of quality management system 
and method of error detection. Similarly, the 
frequency of errors may differ from institution to 
institution and time to time.  
This study provides literature regarding the 
errors in the total testing process in clinical 
laboratories and points out errors in the TTP that 
affect the quality of the laboratory service. 
Therefore, errors detected can be prevented from 
recurring, thus; make better laboratory quality. As 
a limitation to this study, the whole story of errors 
in TTP can not be addressed. Hence, further in-
depth study to evaluate details of errors in TTP, 
including pre-pre-analytical phases such as 
sampling, sample transportation and the like, and 
post-post-analytical phases should be conducted. 
Another limitation was the inability to assess the 
impacts of laboratory errors on patient health and 
the entire healthcare system. These can be a 
possible area for future research.  
In conclusion, this study reported a high 
frequency of errors in the TTP. These indicate a 
need to address shortcomings related to each 
analytical process. Therefore, a continuous 
practice of assessing errors is mandatory to help 
in devising corrective strategies. This helps to 
improve laboratory performance and hence 
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